All Stories

  1. A Fresh Start? A Scoping Review of Health Behavior Change around the New Year
  2. Engagement in alcohol‐free activities, community‐level economic disadvantage, and heavy drinking following alcohol treatment
  3. Examining the Impact of Trial Length on Detecting Medication Effects for Alcohol Use Disorder: A Meta‐Regression Study
  4. The Effects of Personalized Feedback About ALDH2*2 , Alcohol Use, and Associated Health Risks on Drinking Intention and Consumption: The Role of Self‐Efficacy and Perceived Threat
  5. New Year’s Resolutions for Health Behavior Change: A Scoping Review
  6. Re-Envisioning Clinical Science Training: Open Science as One of Many Important Steps
  7. Preliminary predictors of self‐stigma among individuals in a telehealth‐based treatment program for alcohol use disorder
  8. How people decide to consume (more) alcohol when feeling stressed
  9. Seriously considering humor as a therapeutic support for recovery from addiction
  10. Relief craving severity moderates nonpharmacological treatment outcomes in treatment‐seeking older adults with alcohol use disorder
  11. Finding purpose: Integrated latent profile and machine learning analyses identify purpose in life as an important predictor of high-functioning recovery after alcohol treatment
  12. Benzodiazepine misuse and alcohol co-use in college student drinkers: Motives and adverse mental health outcomes
  13. Psychological treatments for comorbid chronic pain and opioid use disorder: Current research and future directions
  14. Positive psychological interventions for substance use, addiction and recovery: An updated systematic review and meta‐analysis
  15. Engaging People With Lived Experience of Psychological Disorders: Current Research and Future Directions for Community-Engaged Measure Development in Psychological Science
  16. How people decide to consume (more) alcohol when feeling stressed
  17. How people decide to consume (more) alcohol when feeling stressed
  18. Impaired or not impaired: The accuracy of the Montreal Cognitive Assessment in detecting cognitive impairment among patients with alcohol use disorder
  19. Recovery from alcohol use disorder: Reinforcer pathology theory, measurement, and methods
  20. A multisite feasibility randomized clinical trial of mindfulness-based resilience training for aggression, stress, and health in law enforcement officers
  21. Whole person recovery from substance use disorder: a call for research examining a dynamic behavioral ecological model of contexts supportive of recovery
  22. Subjective stress and any drinking during alcohol treatment: Disentangling within and between person autoregressive effects
  23. Longitudinal stability of reward and relief drinking phenotypes in community and treatment‐seeking individuals who engage in heavy drinking
  24. Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder
  25. A Tutorial on Analyzing Ecological Momentary Assessment Data in Psychological Research With Bayesian (Generalized) Mixed-Effects Models
  26. Beyond mediators: A critical review and methodological path forward for studying mechanisms in alcohol use treatment research
  27. Comparing the Psychometric Properties of Reward and Relief Drinking Measures
  28. Longitudinal Measurement Invariance of Constructs Derived from the Addiction Cycle
  29. Examining the validity of the drinking motives questionnaire for identifying reward and relief drinking subgroups in college students
  30. Beyond Mediators: A Critical Review and Methodological Path Forward for Studying Mechanisms in Alcohol Use Treatment Research
  31. Patterns of drinking behavior around a treatment episode for alcohol use disorder: Predictions from pre‐treatment measures
  32. A Multisite Feasibility Randomized Clinical Trial of Mindfulness-Based Resilience Training for Aggression, Stress, and Health in Law Enforcement Officers
  33. Electrophysiological Markers of Aberrant Cue-Specific Exploration in Hazardous Drinkers
  34. Engaging people with lived experience of psychological disorders: Current research and future directions for community-engaged measure development in psychological science
  35. Everybody Hurts: Intersecting and Colliding Epidemics and the Need for Integrated Behavioral Treatment of Chronic Pain and Substance Use
  36. Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorder
  37. Pilot randomized controlled trial of mindfulness-based relapse prevention vs cognitive behavioral therapy for smoking and alcohol use
  38. An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial
  39. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels
  40. An Evaluation of Cognitive Behavioral Therapy for Substance Use Disorder: A Systematic Review and Application of the Society of Clinical Psychology Criteria for Empirically Supported Treatments
  41. Examining the Validity of the Addictions Neuroclinical Assessment Domains in a Crowdsourced Sample of Adults with Current Alcohol Use
  42. Examining the Validity of the Addictions Neuroclinical Assessment Domains in a Crowdsourced Sample of Adults with Current Alcohol Use
  43. A tutorial on analyzing ecological momentary assessment data in psychological research with Bayesian (generalized) mixed-effects models
  44. Evidence-Based Assessment of Substance Use Disorder
  45. What Happens When You Smoke a Cigarette Mindfully? A Deductive Qualitative Study
  46. Precision Medicine in Alcohol Use Disorder: Mapping Etiologic and Maintenance Mechanisms to Mechanisms of Behavior Change to Improve Patient Outcomes
  47. Constructs Derived from the Addiction Cycle Predict Alcohol Use Disorder Treatment Outcomes and Recovery Three Years Following Treatment
  48. Constructs derived from the addiction cycle predict alcohol use disorder treatment outcomes and recovery 3 years following treatment.
  49. Mechanisms of quality-of-life improvement in treatment for alcohol use disorder.
  50. Self-Efficacy as a Potential Mechanism of Behavior Change in Mindfulness-Based Relapse Prevention
  51. Predictors of abstinence, no heavy drinking days, and a 2‐level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study
  52. Measurement invariance of the University of Rhode Island Change Assessment Scale in Project MATCH: An exploratory structural equation modeling approach
  53. Limitations of cross-lagged panel models in addiction research and alternative models: An empirical example using project MATCH.
  54. Examining replicability in addictions research: How to assess and ways forward.
  55. Changes in pain during medication treatment among those with chronic pain and opioid use disorder
  56. Alcohol use disorder relapse factors: an exploratory investigation of craving, alcohol dependence severity, and meaning in life
  57. An R Shiny App for Sensitivity Analysis for Latent Growth Curve Mediation
  58. Sex moderates effects of alcohol and cannabis co‐use on alcohol and stress reactivity
  59. A Bayesian mixed effects support vector machine for learning and predicting daily substance use disorder patterns
  60. An Evaluation of Cognitive Behavioral Therapy for Substance Use: An Application of Tolin’s Criteria for Empirically Supported Treatments
  61. Evaluation of Contingency Management (CM) for Substance Use Disorder (SUD)
  62. Dose of psychotherapy and long-term recovery outcomes: An examination of attendance patterns in alcohol use disorder treatment.
  63. An application of moderated nonlinear factor analysis to develop a commensurate measure of alcohol problems across four alcohol treatment studies
  64. Within-AUD outpatient treatment heavy drinking transitions and associations with long-term outcomes
  65. Individual and Community Social Determinants of Health and Recovery from Alcohol Use Disorder Three Years following Treatment
  66. Integrative data analysis of self‐efficacy in 4 clinical trials for alcohol use disorder
  67. Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder
  68. World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials
  69. Alcohol use disorder conceptualizations and diagnoses reflect their sociopolitical context
  70. Neural correlates of alcohol use disorder severity among nontreatment‐seeking heavy drinkers: An examination of the incentive salience and negative emotionality domains of the alcohol and addiction research domain criteria
  71. Do alcohol interventions affect peers who do not receive the intervention? Modeling treatment contagion effects via simulations of adolescent social networks.
  72. Applying methods for personalized medicine to the treatment of alcohol use disorder.
  73. A Longitudinal Mediation Model of Negative Emotionality, Coping Motives and Drinking Intensity Among Individuals Receiving Community Treatment for Alcohol Use Disorder
  74. Reward drinking and naltrexone treatment response among young adult heavy drinkers
  75. Commentary on Henssler et al.: The public health case for promoting and valuing drinking reductions in the treatment of alcohol use disorder
  76. Inaugural editorial.
  77. The Association Between Impulsivity and Relapse in Patients With Alcohol Use Disorder: A Literature Review
  78. Reconsidering alcohol treatment non‐responders: psychosocial functioning among heavy drinkers 3 years following treatment
  79. Patterns of transitions between relapse to and remission from heavy drinking over the first year after outpatient alcohol treatment and their relation to long-term outcomes.
  80. Stability of Drinking Reductions and Long-term Functioning Among Patients with Alcohol Use Disorder
  81. A randomized controlled trial protocol for engaging distress tolerance and working memory to aid smoking cessation in low socioeconomic status (SES) adults.
  82. Culturally tailored evidence‐based substance use disorder treatments are efficacious with an American Indian Southwest tribe: an open‐label pilot‐feasibility randomized controlled trial
  83. Can Alcohol Use Disorder Recovery Include Some Heavy Drinking? A Replication and Extension up to 9 Years Following Treatment
  84. Telephone‐based motivational interviewing enhanced with individualised personality‐specific coping skills training for young people with alcohol‐related injuries and illnesses accessing emergency or rest/recovery services: a randomized controlled trial...
  85. Mindfulness-based programs for substance use disorders: a systematic review of manualized treatments
  86. Reduction in World Health Organization Risk Drinking Levels and Cardiovascular Disease
  87. Can Individuals with Alcohol Use Disorder Achieve and Sustain Non-Abstinent Recovery? Non-Abstinent Outcomes 10 Years After Alcohol Use Disorder Treatment
  88. Latent Class Mediation: A Comparison of Six Approaches
  89. Transcranial direct current stimulation facilitates category learning
  90. World Health Organization Risk Drinking Level Reductions Are Associated with Improved Functioning and Are Sustained Among Patients with Mild, Moderate, and Severe Alcohol Dependence in Clinical Trials in the United States and United Kingdom
  91. The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment‐Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance
  92. Alcohol and Pain: A Translational Review of Preclinical and Clinical Findings to Inform Future Treatment Strategies
  93. Abstinence Not Required: Expanding the Definition of Recovery from Alcohol Use Disorder
  94. Non-invasive brain stimulation in substance use disorders: implications for dissemination to clinical settings
  95. The Indirect Relationship between Interpersonal Trauma History and Alcohol Use via Negative Cognitions in a Multisite Alcohol Treatment Sample
  96. Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response
  97. Recovery from addiction: behavioral economics and value-based decision-making
  98. Advances in the science and treatment of alcohol use disorder
  99. Response to Dr. Mark Litt's Commentary
  100. Mindfulness‐Based Relapse Prevention and Transcranial Direct Current Stimulation to Reduce Heavy Drinking: A Double‐Blind Sham‐Controlled Randomized Trial
  101. Alcohol use disorder and motives for prescription opioid misuse: A latent class analysis
  102. Maintenance of drinking reductions are possible and associated with improvements in functioning.
  103. Consumption outcomes in clinical trials of alcohol use disorder treatment: Consideration of standard drink misestimation
  104. Predictive value of non‐consumption outcome measures in alcohol use disorder treatment
  105. Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder
  106. Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population
  107. Sensitivity Analysis of the No-Omitted Confounder Assumption in Latent Growth Curve Mediation Models
  108. Double standards and gold standards in the evaluation of how a person feels and functions in substance use disorder pharmacotherapy trials
  109. The (Lack of) Replication of Self-Reported Mindfulness as a Mechanism of Change in Mindfulness-Based Relapse Prevention for Substance Use Disorders
  110. Abstinence and low risk drinking during treatment: Association with psychosocial functioning, alcohol use, and alcohol problems 3 years following treatment.
  111. Profiles of recovery from alcohol use disorder at three years following treatment: can the definition of recovery be extended to include high functioning heavy drinkers?
  112. Response to Letter to Editor (Precision medicine in alcohol dependence: evidence of efficacy and initial support for comparative effectiveness)
  113. Opioid Misuse as a Predictor of Alcohol Treatment Outcomes in the COMBINE Study: Mediation by Medication Adherence
  114. Course of remission from and relapse to heavy drinking following outpatient treatment of alcohol use disorder
  115. Alcohol and Opioid Use, Co‐Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review
  116. Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes
  117. Trajectories of positive alcohol expectancies and drinking: An examination of young adults in the US and Sweden
  118. Does self-efficacy causally influence initial smoking cessation? An experimental study
  119. Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials
  120. Viability of the World Health Organization quality of life measure to assess changes in quality of life following treatment for alcohol use disorder
  121. Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population
  122. Identifying “Hitting Bottom” Among Individuals with Alcohol Problems: Development and Evaluation of the Noteworthy Aspects of Drinking Important to Recovery (NADIR)
  123. Letter to Editor in Response to Johnson's Commentary (2017) on the Witkiewitz and Colleagues (2017) Article
  124. Coping mediates the effects of cognitive-behavioral therapy for alcohol use disorder among out-patient clients in Project MATCH when dependence severity is high
  125. Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study
  126. The search for an elusive cutoff remains: Problems of binary classification of heavy drinking as an endpoint for alcohol clinical trials
  127. Are reductions in pain intensity and pain-related distress necessary? An analysis of within-treatment change trajectories in relation to improved functioning following interdisciplinary acceptance and commitment therapy for adults with chronic pain.
  128. Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels
  129. Supplemental Material for Are Reductions in Pain Intensity and Pain-Related Distress Necessary? An Analysis of Within-Treatment Change Trajectories in Relation to Improved Functioning Following Interdisciplinary Acceptance and Commitment Therapy for Ad...
  130. Effects of parental monitoring on alcohol use in the US and Sweden: A brief report
  131. Aggregating and Analyzing Daily Drinking Data in Clinical Trials: A Comparison of Type I Errors, Power, and Bias
  132. Is the Construct of Relapse Heuristic, and Does It Advance Alcohol Use Disorder Clinical Practice?
  133. Fronto-Parietal gray matter and white matter efficiency differentially predict intelligence in males and females
  134. Examining Committed Action in Chronic Pain: Further Validation and Clinical Utility of the Committed Action Questionnaire
  135. Just-in-Time Adaptive Interventions (JITAIs) in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support
  136. Do Alcohol Relapse Episodes During Treatment Predict Long-Term Outcomes? Investigating the Validity of Existing Definitions of Alcohol Use Disorder Relapse
  137. Finding success in failure: using latent profile analysis to examine heterogeneity in psychosocial functioning among heavy drinkers following treatment
  138. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone
  139. Client Evaluation of Treatment for Alcohol Use Disorder in COMBINE
  140. Repeated measures latent class analysis of daily smoking in three smoking cessation studies
  141. Missing Data in Alcohol Clinical Trials with Binary Outcomes
  142. Reductions in Healthcare Costs Following Alcohol Treatment: Moving Toward Low-Risk Drinking End Points in Alcohol Clinical Trials
  143. We still question the utility and validity of the binge/heavy drinking criterion
  144. Adding tools to the toolbox: The role of coping repertoire in alcohol treatment.
  145. Multilevel factor analysis of smokers’ real-time negative affect ratings while quitting.
  146. Reproducibility and differential item functioning of the alcohol dependence syndrome construct across four alcohol treatment studies: An integrative data analysis
  147. Questioning the validity of the 4+/5+ binge or heavy drinking criterion in college and clinical populations
  148. Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders
  149. Indirect Effects of the Fast Track Intervention on Conduct Disorder Symptoms and Callous-Unemotional Traits: Distinct Pathways Involving Discipline and Warmth
  150. Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders
  151. Toward the Operationalization and Examination of “Hitting Bottom” for Problematic Alcohol Use: A Literature Review
  152. Engagement in Buddhist Meditation Practices Among Non-Buddhists: Associations with Religious Identity and Practice
  153. Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial
  154. The Indirect Effect of the Therapeutic Alliance and Alcohol Abstinence Self-Efficacy on Alcohol Use and Alcohol-Related Problems in Project MATCH
  155. Association between physical pain and alcohol treatment outcomes: The mediating role of negative affect.
  156. Examining temptation to drink from an existential perspective: Associations among temptation, purpose in life, and drinking outcomes.
  157. Paths to tobacco abstinence: A repeated-measures latent class analysis.
  158. Protective behavioral strategies and future drinking behaviors: Effect of drinking intentions.
  159. Social Network Moderators of Naltrexone and Behavioral Treatment Effects on Heavy Drinking in the COMBINE Study
  160. The cusp catastrophe model as cross-sectional and longitudinal mixture structural equation models.
  161. Methods to Analyze Treatment Effects in the Presence of Missing Data for a Continuous Heavy Drinking Outcome Measure When Participants Drop Out from Treatment in Alcohol Clinical Trials
  162. Alcohol, tobacco, and drug use among emergency department patients
  163. Relative Efficacy of Mindfulness-Based Relapse Prevention, Standard Relapse Prevention, and Treatment as Usual for Substance Use Disorders
  164. Testing the measurement invariance of the eating disorder inventory in nonclinical samples of Hispanic and Caucasian women
  165. Staying in the Moment and Finding Purpose: The Associations of Trait Mindfulness, Decentering, and Purpose in Life with Depressive Symptoms, Anxiety Symptoms, and Alcohol-Related Problems
  166. Mindfulness-Based Treatment to Prevent Addictive Behavior Relapse: Theoretical Models and Hypothesized Mechanisms of Change
  167. Randomized Trial Comparing Mindfulness-Based Relapse Prevention with Relapse Prevention for Women Offenders at a Residential Addiction Treatment Center
  168. Unresolved Issues in the Application of Mindfulness-Based Interventions for Substance Use Disorders
  169. Acceptance and Commitment Therapy for Chronic Pain: Evidence of Mediation and Clinically Significant Change Following an Abbreviated Interdisciplinary Program of Rehabilitation
  170. Development and evaluation of a mobile intervention for heavy drinking and smoking among college students.
  171. What happens in treatment doesn’t stay in treatment: Cocaine abstinence during treatment is associated with fewer problems at follow-up.
  172. Mindfulness-based relapse prevention with racial and ethnic minority women
  173. Missing Data in Alcohol Clinical Trials: A Comparison of Methods
  174. Mindfulness training for smoking cessation: Moderation of the relationship between craving and cigarette use
  175. Retraining the addicted brain: A review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.
  176. Alcohol use following drug treatment: more than just a risk factor?
  177. The Relationship Between Baseline Drinking Status, Peer Motivational Interviewing Microskills, and Drinking Outcomes in a Brief Alcohol Intervention for Matriculating College Students: A Replication
  178. Mindfulness-based relapse prevention for substance craving
  179. Prospective changes in alcohol use among hazardous drinkers in the absence of treatment.
  180. Relapse and Lapse
  181. The predictive utility of a brief kindergarten screening measure of child behavior problems.
  182. Temptation to Drink as a Predictor of Drinking Outcomes Following Psychosocial Treatment for Alcohol Dependence
  183. “Success” Following Alcohol Treatment: Moving Beyond Abstinence
  184. Evidence for a Multi-Dimensional Latent Structural Model of Externalizing Disorders
  185. Does Session Attendance by a Supportive Significant Other Predict Outcomes in Individual Treatment for Alcohol Use Disorders?
  186. Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility
  187. Relapse prevention: From radical idea to common practice
  188. Concurrent drinking and smoking among college students: An event-level analysis.
  189. Drink refusal training as part of a combined behavioral intervention: Effectiveness and mechanisms of change.
  190. Item analysis and differential item functioning of a brief conduct problem screen.
  191. The moderating effects of group cognitive–behavioral therapy for depression among substance users.
  192. Trajectories of Cigarettes per Day During the Course of Telephone Tobacco Cessation Counseling Services: A Comparison of Missing Data Models
  193. Drinking outcomes following drink refusal skills training: Differential effects for African American and non-Hispanic White clients.
  194. Lapse-induced surges in craving influence relapse in adult smokers: An experimental investigation.
  195. Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence.
  196. Predictors of heavy drinking during and following treatment.
  197. Relapse prevention for addictive behaviors
  198. Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.
  199. Substance abuse and mental health treatment in the military: Lessons learned and a way forward.
  200. Evaluating a Cognitive Model of ALDH2 and Drinking Behavior
  201. A parallel process growth mixture model of conduct problems and substance use with risky sexual behavior
  202. A Comparison of Methods for Estimating Change in Drinking following Alcohol Treatment
  203. Preventing Relapse Following Smoking Cessation
  204. Matching motivation enhancement treatment to client motivation: re-examining the Project MATCH motivation matching hypothesis
  205. Update on Harm-Reduction Policy and Intervention Research
  206. Psychosocial Variables as Mediators of the Relationship Between Childhood History of Emotional Maltreatment, Codependency, and Self-Silencing
  207. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention.
  208. Predictive validity of callous–unemotional traits measured in early adolescence with respect to multiple antisocial outcomes.
  209. Young Investigator Award Symposium
  210. Mindfulness-Based Relapse Prevention for Substance Use Disorders: A Pilot Efficacy Trial
  211. [Commentary] FURTHER EXPLORING THE INTERPERSONAL DYNAMICS OF RELAPSE
  212. Marriage and relationship closeness as predictors of cocaine and heroin use
  213. Dynamic association between negative affect and alcohol lapses following alcohol treatment.
  214. Relapse Prevention
  215. [Commentary] WHY AND HOW DO SUBSTANCE ABUSE TREATMENTS WORK? INVESTIGATING MEDIATED CHANGE
  216. Drinking trajectories following an initial lapse.
  217. The role of thought suppression in the relationship between mindfulness meditation and alcohol use
  218. Modeling the complexity of post-treatment drinking: It's a rocky road to relapse
  219. High-Risk Situations
  220. Nonnormality and divergence in posttreatment alcohol use: Reexamining the Project MATCH data "another way."
  221. Overview of Relapse Prevention
  222. Relapse Prevention for Return of Pathological Worry in CBT-Treated GAD
  223. Therapist's Guide to Evidence-Based Relapse Prevention
  224. Intensive Mindfulness Training and the Reduction of Psychological Distress: A Preliminary Study
  225. Overview of harm reduction treatments for alcohol problems
  226. Mindfulness meditation and substance use in an incarcerated population.
  227. Addiction, Assessment, and Treatment with Adolescents, Adults, and Families
  228. Mindfulness-Based Relapse Prevention for Alcohol and Substance Use Disorders
  229. Emphasis on Interpersonal Factors in a Dynamic Model of Relapse.
  230. Relapse Prevention for Alcohol and Drug Problems: That Was Zen, This Is Tao.
  231. Accessibility of Alcohol-Related Attitudes: A Cross-Lag Panel Model With Young Adults
  232. Relapse as a nonlinear dynamic system: Application to patients with alcohol use disorders.
  233. Harm reduction approaches to alcohol use
  234. Reliability of Scores from the Eysenck Personality Questionnaire: A Reliability Generalization Study
  235. Memory and Reasoning Abilities Assessed by the Universal Nonverbal Intelligence Test: A Reliable Component Analysis (RCA) Study
  236. Recollections of Childhood Psychological Maltreatment and Self-Reported Eating Disordered Behaviors in Undergraduate College Females
  237. The frequence of reliable component difference scores for the Wechsler Intelligence Scale for Children—Third Edition in two samples.
  238. Substance Use Disorders